BC Form 4: Director adds 657 shares at $66.11, total now 9,913

Rhea-AI Filing Summary

Brunswick Corporation (BC) reported an insider transaction by a director. On 10/31/2025, the director acquired 657 shares of common stock at $66.11 (code A). Following this, the director beneficially owns 9,913 shares, held directly.

Footnotes state the acquired shares are deferred shares deposited into the director’s deferred account, to be distributed in predetermined installments after the director ceases serving on the board. Beneficial holdings include 61 shares acquired via dividend reinvestment in September 2025.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Wright MaryAnn

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	657	$66.11	$43K

Holdings After Transaction: Common Stock — 9,913 shares (Direct)

Footnotes (1)

1. Deferred shares deposited in the director's deferred account, which will be automatically distributed in predetermined installments after the director ceases being a director of the Company. Beneficial holdings include 61 shares acquired pursuant to dividend reinvestment in September 2025.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wright MaryAnn

(Last) (First) (Middle)

C/O BRUNSWICK CORPORATION

26125 N. RIVERWOODS BLVD. #500

(Street)

METTAWA IL 60045

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BRUNSWICK CORP [ BC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/31/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/31/2025		A		657(1)	A	$66.11	9,913(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Deferred shares deposited in the director's deferred account, which will be automatically distributed in predetermined installments after the director ceases being a director of the Company.

2. Beneficial holdings include 61 shares acquired pursuant to dividend reinvestment in September 2025.

Remarks:

	By: Power of Attorney: /s/MaryAnn Wright	11/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the BC (Brunswick) director report on Form 4?

The director acquired 657 shares of common stock on 10/31/2025 at $66.11 per share (code A).

How many Brunswick (BC) shares does the director now hold?

After the transaction, the director beneficially owns 9,913 shares, held directly.

What is the nature of the acquired BC shares?

They are deferred shares credited to the director’s deferred account and distributed in installments after board service ends.

Was any dividend reinvestment included in the holdings?

Yes. Beneficial holdings include 61 shares acquired via dividend reinvestment in September 2025.

What price was paid for the acquired BC shares?

The reported price was $66.11 per share.

What was the ownership form reported?

The holdings are reported as Direct (D) ownership.